FDA approval for commercial use • 25%

Integration with another major tech device • 25%

Partnership with a major tech company • 25%

Clinical trials expansion • 25%

Communication enhancement for ALS patients • 25%

Cognitive enhancement for general users • 25%

Control of tech devices like Apple Vision Pro • 25%

Medical research and trials • 25%

Speech restoration • 25%

Motor function restoration • 25%

Sensory restoration • 25%

Other • 25%

Other • 25%

Improved accuracy over 99% • 25%

Reduced size and invasiveness • 25%

Extended functionality beyond speech • 25%

Communication for paralyzed patients • 25%

Assisting patients with ALS • 25%

Supporting stroke recovery • 25%

Other • 25%

Yes • 50%

No • 50%

Healthcare • 25%

Education • 25%

Communication • 25%

Other • 25%

Yes • 50%

No • 50%

Neurological condition diagnosis • 25%

Mental health monitoring • 25%

Brain-computer interfaces • 25%

Other • 25%

Increased accuracy above 99% • 25%

Wider commercial availability • 25%

Use in other neurological conditions • 25%

Other • 25%

Yes • 50%

No • 50%

Yes • 50%

No • 50%